Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation

Gergely Kriván, János Sinkó, Ildikó Zsolnai Nagy, Vera Goda, Péter Reményi, Árpád Bátai, Sándor Lueff, Balázs Kapás, Marienn Réti, Anna Tremmel, T. Masszi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The emergence of new antifungal compounds with alternative mechanisms of action and improved tolerability has opened up new therapeutic possibilities for the use of combined antifungal treatment in life-threatening systemic fungal infections. A case report of an 8-year-old allogeneic stem cell transplant recipient who developed a central venous catheter tunnel infection caused by Aspergillus flavus is presented here. In spite of conventional and subsequent liposomal amphotericin B therapy the infection progressed rapidly and the necrosis extended further to the thoracic wall, pleura and the right lung. Combined treatment consisting of liposomal amphotericin B and caspofungin was instituted. After 30 days of dual therapy the deep fungal infection resolved and the extensive soft tissue defect showed scarring. One year post-transplant, the patient is well, with normal bone marrow function and full donor chimerism. Although there is limited clinical data on the effectiveness of echinocandins in pediatric patients with documented invasive fungal infections, this case report shows that combining liposomal amphotericin B with caspofungin could be advantageous.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalActa bio-medica de L'Ateneo parmense : organo della Società di medicina e scienze naturali di Parma
Volume77
Issue numberSUPPL. 2
Publication statusPublished - 2006

Fingerprint

caspofungin
Aspergillus flavus
Salvage Therapy
Homologous Transplantation
Bone Marrow Transplantation
Mycoses
Infection
Echinocandins
Transplants
Chimerism
Central Venous Catheters
Pleura
Thoracic Wall
Therapeutic Uses
Therapeutics
Cicatrix
Necrosis
Stem Cells
Bone Marrow
Tissue Donors

Keywords

  • Antifungal compounds
  • Aspergillus flavus
  • Tolerability

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation. / Kriván, Gergely; Sinkó, János; Nagy, Ildikó Zsolnai; Goda, Vera; Reményi, Péter; Bátai, Árpád; Lueff, Sándor; Kapás, Balázs; Réti, Marienn; Tremmel, Anna; Masszi, T.

In: Acta bio-medica de L'Ateneo parmense : organo della Società di medicina e scienze naturali di Parma, Vol. 77, No. SUPPL. 2, 2006, p. 17-21.

Research output: Contribution to journalArticle

Kriván, Gergely ; Sinkó, János ; Nagy, Ildikó Zsolnai ; Goda, Vera ; Reményi, Péter ; Bátai, Árpád ; Lueff, Sándor ; Kapás, Balázs ; Réti, Marienn ; Tremmel, Anna ; Masszi, T. / Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation. In: Acta bio-medica de L'Ateneo parmense : organo della Società di medicina e scienze naturali di Parma. 2006 ; Vol. 77, No. SUPPL. 2. pp. 17-21.
@article{e1256095bec0492ead801384dd566afd,
title = "Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation",
abstract = "The emergence of new antifungal compounds with alternative mechanisms of action and improved tolerability has opened up new therapeutic possibilities for the use of combined antifungal treatment in life-threatening systemic fungal infections. A case report of an 8-year-old allogeneic stem cell transplant recipient who developed a central venous catheter tunnel infection caused by Aspergillus flavus is presented here. In spite of conventional and subsequent liposomal amphotericin B therapy the infection progressed rapidly and the necrosis extended further to the thoracic wall, pleura and the right lung. Combined treatment consisting of liposomal amphotericin B and caspofungin was instituted. After 30 days of dual therapy the deep fungal infection resolved and the extensive soft tissue defect showed scarring. One year post-transplant, the patient is well, with normal bone marrow function and full donor chimerism. Although there is limited clinical data on the effectiveness of echinocandins in pediatric patients with documented invasive fungal infections, this case report shows that combining liposomal amphotericin B with caspofungin could be advantageous.",
keywords = "Antifungal compounds, Aspergillus flavus, Tolerability",
author = "Gergely Kriv{\'a}n and J{\'a}nos Sink{\'o} and Nagy, {Ildik{\'o} Zsolnai} and Vera Goda and P{\'e}ter Rem{\'e}nyi and {\'A}rp{\'a}d B{\'a}tai and S{\'a}ndor Lueff and Bal{\'a}zs Kap{\'a}s and Marienn R{\'e}ti and Anna Tremmel and T. Masszi",
year = "2006",
language = "English",
volume = "77",
pages = "17--21",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation

AU - Kriván, Gergely

AU - Sinkó, János

AU - Nagy, Ildikó Zsolnai

AU - Goda, Vera

AU - Reményi, Péter

AU - Bátai, Árpád

AU - Lueff, Sándor

AU - Kapás, Balázs

AU - Réti, Marienn

AU - Tremmel, Anna

AU - Masszi, T.

PY - 2006

Y1 - 2006

N2 - The emergence of new antifungal compounds with alternative mechanisms of action and improved tolerability has opened up new therapeutic possibilities for the use of combined antifungal treatment in life-threatening systemic fungal infections. A case report of an 8-year-old allogeneic stem cell transplant recipient who developed a central venous catheter tunnel infection caused by Aspergillus flavus is presented here. In spite of conventional and subsequent liposomal amphotericin B therapy the infection progressed rapidly and the necrosis extended further to the thoracic wall, pleura and the right lung. Combined treatment consisting of liposomal amphotericin B and caspofungin was instituted. After 30 days of dual therapy the deep fungal infection resolved and the extensive soft tissue defect showed scarring. One year post-transplant, the patient is well, with normal bone marrow function and full donor chimerism. Although there is limited clinical data on the effectiveness of echinocandins in pediatric patients with documented invasive fungal infections, this case report shows that combining liposomal amphotericin B with caspofungin could be advantageous.

AB - The emergence of new antifungal compounds with alternative mechanisms of action and improved tolerability has opened up new therapeutic possibilities for the use of combined antifungal treatment in life-threatening systemic fungal infections. A case report of an 8-year-old allogeneic stem cell transplant recipient who developed a central venous catheter tunnel infection caused by Aspergillus flavus is presented here. In spite of conventional and subsequent liposomal amphotericin B therapy the infection progressed rapidly and the necrosis extended further to the thoracic wall, pleura and the right lung. Combined treatment consisting of liposomal amphotericin B and caspofungin was instituted. After 30 days of dual therapy the deep fungal infection resolved and the extensive soft tissue defect showed scarring. One year post-transplant, the patient is well, with normal bone marrow function and full donor chimerism. Although there is limited clinical data on the effectiveness of echinocandins in pediatric patients with documented invasive fungal infections, this case report shows that combining liposomal amphotericin B with caspofungin could be advantageous.

KW - Antifungal compounds

KW - Aspergillus flavus

KW - Tolerability

UR - http://www.scopus.com/inward/record.url?scp=33845340456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845340456&partnerID=8YFLogxK

M3 - Article

C2 - 16918062

AN - SCOPUS:33845340456

VL - 77

SP - 17

EP - 21

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

IS - SUPPL. 2

ER -